Numorphan Articles
Opana growth drives Endo's profit up 15%
16 March 2009
Endo/Penwest settle Opana litigation
2 March 2009
FDA clears three new Opana ER strengths
10 March 2008
Endo Pharma sees 2nd-qtr profits slump
26 July 2004
Endo net sales surge 49% in 2003
23 February 2004
Penwest to make $40M placing
11 August 2003
Endo's oxymorphone shows promise in back pain
31 March 2003
Endo files for oxymorphone approvals
6 January 2003
Showing 1-9 of 9 articles
- 1
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Negative US patent ruling for Novo Nordisk on Prandin
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Daiichi Sankyo files for Japanese approval of Prasugrel
